123 related articles for article (PubMed ID: 23814214)
1. Lungs on fire.
Batra S; Vaid AK; Bhargava R; Gupta S
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814214
[TBL] [Abstract][Full Text] [Related]
2. Can We Predict Bleomycin Toxicity with PET-CT?
Beyhan Sagmen S; Comert S; Turan Erkek E; Küçüköz Uzun A; Doğan C; Yılmaz G; Kıral N; Fidan A; Yılmaz Haksal Ç; Torun Parmaksız E
Acta Haematol; 2019; 142(3):171-175. PubMed ID: 31454795
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
Buchler T; Bomanji J; Lee SM
Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389
[TBL] [Abstract][Full Text] [Related]
4. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.
Kirsch J; Arrossi AV; Yoon JK; Wu G; Neumann DR
J Thorac Imaging; 2006 Aug; 21(3):228-30. PubMed ID: 16915070
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.
Sher DJ; Mauch PM; Van Den Abbeele A; LaCasce AS; Czerminski J; Ng AK
Ann Oncol; 2009 Nov; 20(11):1848-53. PubMed ID: 19541793
[TBL] [Abstract][Full Text] [Related]
6. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Press OW; Li H; Schöder H; Straus DJ; Moskowitz CH; LeBlanc M; Rimsza LM; Bartlett NL; Evens AM; Mittra ES; LaCasce AS; Sweetenham JW; Barr PM; Fanale MA; Knopp MV; Noy A; Hsi ED; Cook JR; Lechowicz MJ; Gascoyne RD; Leonard JP; Kahl BS; Cheson BD; Fisher RI; Friedberg JW
J Clin Oncol; 2016 Jun; 34(17):2020-7. PubMed ID: 27069074
[TBL] [Abstract][Full Text] [Related]
7. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma.
Falay O; Öztürk E; Bölükbaşı Y; Gümüş T; Örnek S; Özbalak M; Çetiner M; Demirkol O; Ferhanoğlu B
Leuk Lymphoma; 2017 May; 58(5):1114-1122. PubMed ID: 28185527
[TBL] [Abstract][Full Text] [Related]
8. 2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma.
Picardi M; Fonti R; Della Pepa R; Giordano C; Pugliese N; Nicolai E; Salvatore M; Mainolfi C; Venetucci P; Rascato MG; Cappuccio I; Mascolo M; Vigliar E; Troncone G; Del Vecchio S; Pane F
Eur J Cancer; 2020 Jun; 132():85-97. PubMed ID: 32334339
[TBL] [Abstract][Full Text] [Related]
9. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
Simontacchi G; Filippi AR; Ciammella P; Buglione M; Saieva C; Magrini SM; Livi L; Iotti C; Botto B; Vaggelli L; Re A; Merli F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1077-1083. PubMed ID: 26031367
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced alveolitis detected by FDG positron emission tomography.
Hain SF; Beggs AD
Clin Nucl Med; 2002 Jul; 27(7):522-3. PubMed ID: 12072783
[No Abstract] [Full Text] [Related]
11. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
[TBL] [Abstract][Full Text] [Related]
12. Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
Okosun J; Warbey V; Shaw K; Montoto S; Fields P; Marcus R; Virchis A; McNamara C; Bower M; Cwynarski K
AIDS; 2012 Apr; 26(7):861-5. PubMed ID: 22333746
[TBL] [Abstract][Full Text] [Related]
13. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin Toxicity - Findings on FDG PET CT.
Mufty S; Razi M; Hassan A
J Pak Med Assoc; 2021 Sep; 71(9):2287-2288. PubMed ID: 34580536
[TBL] [Abstract][Full Text] [Related]
15. Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
Younes A; Connors JM; Park SI; Fanale M; O'Meara MM; Hunder NN; Huebner D; Ansell SM
Lancet Oncol; 2013 Dec; 14(13):1348-56. PubMed ID: 24239220
[TBL] [Abstract][Full Text] [Related]
16. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Song MK; Chung JS; Lee JJ; Jeong SY; Lee SM; Hong JS; Chong A; Moon JH; Kim JH; Lee SM; Kim SJ; Shin HJ
Cancer Sci; 2013 Dec; 104(12):1656-61. PubMed ID: 24033666
[TBL] [Abstract][Full Text] [Related]
17. The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Burger IA; Vargas HA; Goldman DA; Gonen M; Kumar A; Zelenetz AD; Schöder H; Hricak H
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):701-7. PubMed ID: 23389428
[TBL] [Abstract][Full Text] [Related]
18. Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.
Orlacchio A; Schillaci O; Gaspari E; Della Gatta F; Danieli R; Bolacchi F; Ragano Caracciolo C; Mancini A; Simonetti G
Radiol Med; 2012 Oct; 117(7):1250-63. PubMed ID: 22327919
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma.
Ngeow J; Tan IB; Kanesvaran R; Tan HC; Tao M; Quek R; Lim ST
Ann Hematol; 2011 Jan; 90(1):67-72. PubMed ID: 20676640
[TBL] [Abstract][Full Text] [Related]
20. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
Ciammella P; Filippi AR; Simontacchi G; Buglione M; Botto B; Mangoni M; Iotti C; Merli F; Marcheselli L; Bisi G; Ricardi U; Versari A
Br J Radiol; 2016; 89(1061):20150983. PubMed ID: 27022777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
